Airsonett
2 known investors
Airsonett develops the Air4, a CE-marked Class 1 medical device that uses patented Temperature-controlled Laminar Airflow (TLA) to deliver clean, allergen-free air around a patient's face during sleep for home treatment of allergic asthma and atopic dermatitis. It serves patients with allergic diseases, primarily in Sweden and the UK.
HardwareHealthtechMedical Devices
Investors · 2
In the news
Frequently asked questions
- What does Airsonett do?
- Airsonett develops the Air4, a CE-marked Class 1 medical device that uses patented Temperature-controlled Laminar Airflow (TLA) to deliver clean, allergen-free air around a patient's face during sleep for home treatment of allergic asthma and atopic dermatitis. It serves patients with allergic diseases, primarily in Sweden and the UK.
- Who are Airsonett's investors?
- Airsonett's investors include FSG, Industrifonden.